ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 120,80
-0,94%
Dow Jones
42 801,72
0,52%
DAX
23 008,94
-1,87%
Brent Oil
70,235
0,00%
Bitcoin
83 014,20
-3,64%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Beam Therapeutics Inc (BEAM) Cours

Beam Therapeutics Inc

Beam Therapeutics Inc (BEAM)

NASDAQ
28,48
1,23
(4,51%)
Fermé 09 Mars 9:00PM
Retardé de 15 minutes
28,49
0,01
(0,04%)
Après les heures de négociation: 1:22AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
28,49
Prix Achat
22,00
Prix Vente
36,56
Volume échangé
1 329 744
26,54 Fourchette du Jour 29,05
20,84 Plage de 52 semaines 39,07
Cap du marché
2,384B
Clôture Veille
27,25
Ouverture
26,89
Dernière Transaction
10
@
28.5
Dernière heure de transaction
Volume financier
US$ 36 895 605
VWAP
27,7464
Volume moyen (3 m)
1 279 236
Actions en circulation
83 688 295
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-6,32
Bénéfice par action (BPA)
-4,5
Chiffre d'affairess
63,52M
Bénéfice net
-376,7M

À propos de Beam Therapeutics Inc

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio co... Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.beamtx.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Beam Therapeutics Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker BEAM. Le dernier cours de clôture d'Beam Therapeutics était de US$27,25. Au cours de la dernière année, les actions de Beam Therapeutics ont été négociées dans une fourchette de prix de US$ 20,84 à US$ 39,07.

Beam Therapeutics compte actuellement 83 688 295 actions en circulation. La capitalisation boursière d'Beam Therapeutics est de US$2,28 milliard. Beam Therapeutics a un ratio cours/bénéfice (ratio PE) de -6.32.

Flux d'options Beam Therapeutics (BEAM)

Voir le flux d'options complet

Flux global

Baissier

Prime nette

-197k

Calls / Puts

33,33%

Ach. / Vent.

100,00%

OTM / ITM

33,33%

Sweeps Ratio

0,00%

BEAM Dernières nouvelles

Plus de nouvelles

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
25 Février 2025
BEAM (4,51%)

Form 8-K - Current report
Edgar (US Regulatory)
25 Février 2025
BEAM (4,51%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
20 Février 2025
BEAM (4,51%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 Février 2025
BEAM (4,51%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
14 Février 2025
BEAM (4,51%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
03 Février 2025
BEAM (4,51%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
03 Février 2025
BEAM (4,51%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
03 Février 2025
BEAM (4,51%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
11.726.4251027269326.7728.4923.63157277826.27806225CS
40.953.4495279593327.5435.2523.63154465129.30768179CS
120.682.4451636102127.8135.2522.5127923627.57517003CS
265.1722.169811320823.3235.2521.135114107926.40510663CS
52-9.94-25.865209471838.4339.0720.84118150826.5009177CS
156-35.89-55.747126436864.3873.2716.95112725333.90708773CS
2606.5229.676832043721.97138.52191396000145.32794528CS

BEAM - Frequently Asked Questions (FAQ)

What is the current Beam Therapeutics share price?
The current share price of Beam Therapeutics is US$ 28,49
How many Beam Therapeutics shares are in issue?
Beam Therapeutics has 83 688 295 shares in issue
What is the market cap of Beam Therapeutics?
The market capitalisation of Beam Therapeutics is USD 2,28B
What is the 1 year trading range for Beam Therapeutics share price?
Beam Therapeutics has traded in the range of US$ 20,84 to US$ 39,07 during the past year
What is the PE ratio of Beam Therapeutics?
The price to earnings ratio of Beam Therapeutics is -6,32
What is the cash to sales ratio of Beam Therapeutics?
The cash to sales ratio of Beam Therapeutics is 37,51
What is the reporting currency for Beam Therapeutics?
Beam Therapeutics reports financial results in USD
What is the latest annual turnover for Beam Therapeutics?
The latest annual turnover of Beam Therapeutics is USD 63,52M
What is the latest annual profit for Beam Therapeutics?
The latest annual profit of Beam Therapeutics is USD -376,7M
What is the registered address of Beam Therapeutics?
The registered address for Beam Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Beam Therapeutics website address?
The website address for Beam Therapeutics is www.beamtx.com
Which industry sector does Beam Therapeutics operate in?
Beam Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ABLVAble View Global Inc
US$ 1,73
(137,18%)
5,14M
SUNESUNation Energy Inc
US$ 0,402999
(127,55%)
482,05M
BTOGBit Origin Ltd
US$ 0,6117
(118,46%)
622,67M
DWTXDogwood Therapeutics Inc
US$ 6,63
(49,66%)
25,92M
KZIAKazia Therapeutics Ltd
US$ 1,1899
(40,80%)
4,5M
ALBTAvalon GloboCare Corporation
US$ 6,96
(-36,15%)
577,55k
SCNXScienture Holdings Inc
US$ 1,55
(-35,68%)
1,59M
ACXPAcurx Pharmaceuticals Inc
US$ 0,4572
(-29,88%)
1,18M
RETOReTo Eco Solutions Inc
US$ 5,42
(-27,73%)
108,27k
OCTOEightco Holdings Inc
US$ 1,08
(-27,03%)
336,99k
BTOGBit Origin Ltd
US$ 0,6117
(118,46%)
622,67M
SUNESUNation Energy Inc
US$ 0,402999
(127,55%)
482,05M
NVDANVIDIA Corporation
US$ 112,69
(1,92%)
341,94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,675
(-0,70%)
143,04M
ICONIcon Energy Corporation
US$ 0,169898
(17,17%)
142,23M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
BEAM
Beam Therapeutics
BIT
UB26F0
UniCredit Bank
USOTC
MTRO
Metro One Development (CE)
BIT
UC20Q8
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces